product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Human anti HSPA4
catalog :
HCA273
quantity :
0.1 mg
price :
264 USD
clonality :
recombinant
host :
human
conjugate :
nonconjugated
clone name :
AbD23625_hIgG1
reactivity :
human
application :
western blot
more info or order :
image
image 1 :
Western blot analysis was performed by loading 25µl MCF7 lysate (Lanes 2-7) onto an AnykD Criterion TGX Stain-Free gel . Precision Plus Protein Prestained Standards were run in lane 1. Lanes 2 & 3 and 5 & 6 were probed with Human anti HSPA4, clone AbD23625_hIgG1 (HCA273) at 1.25µg/ml (lanes 2 & 5) and 0.625µg/ml (lanes 3 & 6). Lanes 2-4 were probed with HRP conjugated Tidyblot (STAR209P) at 1/200. Lanes 5-7 were probed with HRP conjugated Goat anti Human IgG F(ab')2 antibody (STAR126P) at 1/2500. Visualization was carried out using the Bio-Rad Chemidoc Touch Imaging System
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
HCA273
Description :
Human anti HSPA4
Specificity :
HSPA4
TargetSpecies :
Human
Host :
Human
Format :
Purified
Isotypes :
IgG1
Applications :
WB
ApplicationTypes :
Western Blotting
Clone :
AbD23625_hIgG1
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0006986,GO:0005524,GO:0005634,GO:0005737,GO:0034619,GO:0045040
GOTerms :
response to unfolded protein,ATP binding,nucleus,cytoplasm,cellular chaperone-mediated protein complex assembly,protein import into mitochondrial outer membrane
Uniprot Accessions :
P34932
Gene :
HSPA4
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3308
Published Synonyms :
Heat Shock 70 Kda Protein 4
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 0.5 mg/ml
Product Form :
Human IgG1 antibody selected from the HuCAL phage display library and expressed in a human cell line - liquid
PriceGBP :
189
PriceEUR :
264
PriceUSD :
264 USD
PriceCHF :
287
PriceSEK :
2878
PriceNOK :
2892
PriceDKK :
1968
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.